Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, talks about the shift in focus that is needed to improve care for patients with asthma.
Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, talks about the shift in focus that is needed to improve care for patients with asthma.
Transcript:
What are some improvements that are needed to improve asthma care?
Winders: Asthma care needs to be improved across the continuum. So, certainly a mild asthma, we've see areas of improvement and things like initial diagnosis and treatment, not prescribing albuterol alone for those mild asthma patients, is a critical effort that we are leading at the Global Allergy and Airways Patient Platform. And then, when we talk about the moderate-to-severe population, it's making sure that there's good inhaler technique, that patients have access to their controller preventer medication in addition to quick relief on a limited basis. But when their disease is uncontrolled or when it's escalating, when the severity level is such that it's not well managed or well controlled, that patients know where to turn and don't have to wait months or even years to get access to that level of specialty care because that's really where they will learn about some of the more targeted personalized treatments that are available for patients today.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More